In our study, lower CALML3-AS1 levels were detected in cervical ADC and non-CC compared with cervical SCC, indicating this molecule may be further explored as a molecular target for specific diagnosis of this histological tumor type. This evidence concerns the gene CALML3 and neoplasm.